COX6CP4

Across TCGA pan-cancer cohorts, COX6CP4 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated COX6CP4 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher COX6CP4 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated COX6CP4 expression acts as an unfavorable survival marker.

COAD, KICH, and LUAD are the cancer types where COX6CP4 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.082	0.871	<.001	108	view →
KICH	DFS	Tertile	All	0.025	0.900	<.001	81	view →
LUAD	OS	Tertile	All	0.246	0.679	<.001	72	view →
ACC	DFS	Tertile	All	0.046	0.753	<.001	54	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
CESC	DFS	Tertile	III,IV	0.190	0.727	.006	36	view →
TGCT	DFS	Tertile	All	0.071	0.673	.026	18	view →
SARC	OS	Tertile	All	0.678	0.845	.005	12	view →
LIHC	OS	Tertile	II,III,IV	0.122	0.617	.028	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

COX6CP4–COAD (OS)

Open the COAD breakdown →